KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to -$37.24.

  • Bausch Health Companies' Debt to Equity rose 5809.42% to -$37.24 in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.24, marking a year-over-year increase of 5809.42%. This contributed to the annual value of -$16.9 for FY2024, which is 2284.92% up from last year.
  • Per Bausch Health Companies' latest filing, its Debt to Equity stood at -$37.24 for Q3 2025, which was up 5809.42% from -$28.45 recorded in Q2 2025.
  • Bausch Health Companies' 5-year Debt to Equity high stood at $142.43 for Q1 2023, and its period low was -$666.29 during Q4 2021.
  • Moreover, its 5-year median value for Debt to Equity was -$37.24 (2025), whereas its average is -$69.58.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 178488.17% in 2021, then surged by 32475.89% in 2022.
  • Bausch Health Companies' Debt to Equity (Quarter) stood at -$666.29 in 2021, then surged by 111.99% to $79.87 in 2022, then plummeted by 127.43% to -$21.91 in 2023, then grew by 22.85% to -$16.9 in 2024, then tumbled by 120.36% to -$37.24 in 2025.
  • Its last three reported values are -$37.24 in Q3 2025, -$28.45 for Q2 2025, and -$18.18 during Q1 2025.